Aquilo Partners, L.P.
One Maritime Plaza, 14th Floor
San Francisco, CA 94111
Member FINRA/SIPC
VaxGen (OTCBB:VXGN) Acquisition by OXiGENE (Nasdaq:OXGN) – VaxGen shareholders to receive:
- 15.6 million shares OXiGENE stock on closing
- Up to 8.5 million additional shares OXiGENE stock upon achievement of specific milestones within 2 years after closing
Definitive Agreement: October 2009
Closing: Pending Location: South San Francisco, CA President: James P. Panek Board of Directors: James P. Panek, Franklin M. Berger, Kevin Reilly, Lori F. Rafield, Ph.D., Paul DeStefano
- Aquilo Partners was engaged by VaxGen’s Board of Directors to issue a fairness opinion.
